Compugen (CGEN) Shares Outstanding (Weighted Average) (2009 - 2026)
Compugen recorded quarterly Shares Outstanding (Weighted Average) of $94.6 million in Q1 2026, up 1.21% quarter-over-quarter from $93.4 million in Q4 2025, and up 2.44% year-over-year from $92.3 million in Q1 2025.
Compugen's Shares Outstanding (Weighted Average) history runs 12 years deep, the most recent figure standing at $94.6 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Weighted Average) rose 2.44% year-over-year to $94.6 million; the TTM figure through Mar 2026 stood at $94.6 million (up 2.44% YoY), while the FY2025 annual figure was $93.4 million, up 4.35% from the prior year.
- Shares Outstanding (Weighted Average) came in at $94.6 million for Q1 2026 at Compugen, up from $93.4 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $94.6 million in Q1 2026 to a low of $86.6 million in Q4 2022.
- A 5-year average of $90.7 million and a median of $90.9 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
- Across the five-year window, Shares Outstanding (Weighted Average) advanced 1.25% in 2023 and advanced 4.35% in 2025, its largest moves.
- Compugen's Shares Outstanding (Weighted Average) stood at $86.6 million in 2022, then rose by 1.25% to $87.6 million in 2023, then grew by 2.16% to $89.5 million in 2024, then gained by 4.35% to $93.4 million in 2025, then grew by 1.21% to $94.6 million in 2026.
- According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods registered $94.6 million, $93.4 million, and $92.3 million for Q1 2026, Q4 2025, and Q1 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 177,333.76 Bn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 185,491.37 Bn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 100.00 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 55.66 Bn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 118.76 Bn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 254.10 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 16.04 Bn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 104.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 132.89 Mn |
| 10 | Compugen | 234.03 Mn | 142.28 Mn | 352,000.00 | 94.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 94.56 Mn |
| Dec 31, 2025 | 93.43 Mn |
| Jun 30, 2025 | 160.00 |
| Mar 31, 2025 | 92.31 Mn |
| Dec 31, 2024 | 89.53 Mn |
| Jun 30, 2024 | 100.00 |
| Mar 31, 2024 | 89.51 Mn |
| Dec 31, 2023 | 87.63 Mn |
| Sep 30, 2023 | 88.31 Mn |
| Jun 30, 2023 | 210.00 |
| Mar 31, 2023 | 86.62 Mn |
| Dec 31, 2022 | 86.56 Mn |
| Sep 30, 2022 | 86.62 Mn |
| Jun 30, 2022 | 220.00 |
| Mar 31, 2022 | 86.45 Mn |
| Dec 31, 2021 | 84.20 Mn |
| Sep 30, 2021 | 83.98 Mn |
| Jun 30, 2021 | 230.00 |
| Mar 31, 2021 | 83.68 Mn |
| Dec 31, 2020 | 79.59 Mn |
| Sep 30, 2020 | 83.17 Mn |
| Jun 30, 2020 | 180.00 |
| Mar 31, 2020 | 70.28 Mn |
| Dec 31, 2019 | 63.64 Mn |
| Sep 30, 2019 | 65.41 Mn |
| Jun 30, 2019 | 240.00 |
| Mar 31, 2019 | 60.02 Mn |
| Dec 31, 2018 | 55.28 Mn |
| Sep 30, 2018 | 57.21 Mn |
| Jun 30, 2018 | 190.00 |
| Dec 31, 2017 | 51.18 Mn |
| Sep 30, 2017 | 51.16 Mn |
| Jun 30, 2017 | 350.00 |
| Mar 31, 2017 | 51.13 Mn |
| Dec 31, 2016 | 50.86 Mn |
| Sep 30, 2016 | 50.93 Mn |
| Jun 30, 2016 | 300.00 |
| Mar 31, 2016 | 50.63 Mn |
| Dec 31, 2015 | 50.44 Mn |
| Sep 30, 2015 | 50.47 Mn |
| Jun 30, 2015 | 260.00 |
| Mar 31, 2015 | 50.34 Mn |
| Dec 31, 2014 | 47.81 Mn |
| Sep 30, 2014 | 49.09 Mn |
| Jun 30, 2014 | 90.00 |
| Mar 31, 2014 | 43.45 Mn |
| Dec 31, 2013 | 38.87 Mn |
| Sep 30, 2013 | 39.15 Mn |
| Jun 30, 2013 | 170.00 |
| Mar 31, 2013 | 37.28 Mn |
| Dec 31, 2012 | 35.84 Mn |
| Jun 30, 2012 | 130.00 |
| Mar 31, 2012 | 35.29 Mn |
| Dec 31, 2011 | 34.28 Mn |
| Sep 30, 2011 | 34.32 Mn |
| Jun 30, 2011 | 120.00 |
| Mar 31, 2011 | 34.09 Mn |
| Dec 31, 2010 | 33.28 Mn |
| Sep 30, 2010 | 33.31 Mn |
| Jun 30, 2010 | 110.00 |
| Mar 31, 2010 | 33.01 Mn |
| Dec 31, 2009 | 28.61 Mn |
| Sep 30, 2009 | 60.00 |
| Mar 31, 2009 | 28.51 Mn |